Aura Biosciences
Clinical trials sponsored by Aura Biosciences, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye injection could shrink metastatic tumors in the eye Results expected Nov 2026 (estimated)
- New bladder cancer drug gets first human test Results expected Mar 2027 (estimated)
-
New eye injection could shrink metastatic tumors in the eye
Disease control Recruiting nowThis Phase 2 trial tests a drug called belzupacap sarotalocan (AU-011) for people whose cancer has spread to the choroid, the layer of blood vessels in the eye. The drug is injected into the eye and then activated with a laser. The study aims to see if it is safe and can shrink o…
Phase 2 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
How does eye cancer treatment affect daily life? new study aims to find out
Knowledge-focused Recruiting nowThis study tracks how choroidal melanoma and its treatment affect patients' quality of life. It involves 15 people already in a larger Phase 3 trial. Participants fill out questionnaires about their well-being over two years. No new drugs or procedures are tested here.
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC